Health Technology

GE Healthcare Unveils New AI and Digital Technologies and Solutions to Help Solve Healthcare’s Most Pressing Problems

At the Radiological Society of North America’s (RSNA) 2021 Annual Meeting, GE Healthcare unveiled around 60 innovative technology solutions spanning the healthcare spectrum including patient screening, diagnostics, therapy planning, guidance, and monitoring. Amidst a global pandemic and mounting pressure on the industry, the company accelerated innovations underpinned by artificial intelligence (AI) and digital solutions to help transform healthcare delivery, making it easier and more efficient for clinicians and health systems, and more personalized and precise for patients.

The pandemic exposed the fragility of the global healthcare system, creating an urgent need for technology and solutions that help clinicians manage seriously ill COVID-19 patients, advanced diseases – such as cancer and heart disease – a backlog in non-urgent care, and an ageing population, while battling burnout and workforce shortages.

With these circumstances in mind, GE Healthcare is proud to introduce technologies and solutions at #RSNA21 that help healthcare systems:

  • Increase efficiency and productivity;
  • Reduce clinician burnout;
  • Empower clinicians with AI and analytics when, where and how they need it;
  • Create a more resilient and sustainable healthcare industry; and
  • Increase access to care.


“Our goal is to make healthcare more human by breaking down barriers so clinicians can work at the top of their game, healthcare systems can operate more efficiently, and patients can get the best and most personalized care possible. Healthcare is at a turning point and at GE Healthcare we are using our clinical expertise and know-how to deliver innovative technologies and solutions that help solve healthcare’s most pressing problems, advance precision health and improve patient lives.”

Kieran Murphy, president & CEO, GE Healthcare

Transforming healthcare through imaging technologies and digital offerings

Over the last year and a half, the industry has embraced technological innovation. What was once considered “futuristic” is now fundamental. In an environment where clinical expertise, regulatory know-how and speed matter, GE Healthcare rose to the challenge. Working alongside clinicians and care teams to understand the most pressing needs of radiologists and hospital administrators, the company innovated new solutions, leveraging its healthcare-specific intelligence platform, Edison, to help providers achieve greater efficiency, reduce errors, increase speed to appropriate treatments, and increase access to care.

To this end, GE Healthcare developed the following new AI-powered, automated and data-driven solutions to help encourage greater diagnostic confidence, ease the burden of care and improve workflow for healthcare systems around the world:

  • SIGNA Hero is named for our heroes on the frontlines, who continue to care for seriously ill patients as well as a backlog in non-urgent care – all the while battling burnout and workforce shortages. The new 3.0T MRI system offers new workflows and AIR Recon DL enhancements designed to help our heroes on the frontlines address some of today’s most pressing healthcare needs: enhanced productivity, patient comfort, and sustainabilityii.
  • SIGNA Artist Evo enables healthcare systems to modernize their legacy 1.5T narrow 60 cm bore MR systems to 1.5T, 70 cm bore systems, accommodating more patients of different shapes and sizes. Furthermore, the company’s patented flexible AIR Coils design and AIR Recon DL image reconstruction help provide clearer, sharper and more detailed images faster – enabling shorter patient setup times and reducing table time.
  • Revolution Apex platform provides exceptional image quality and low dose scanning for routine and challenging cases in many care areas with optimized clinical capabilities, built-in scalability and upgradability options.
  • Allia Platform is designed to enhance user experience, improve workflow efficiency and increase the adoption of advanced image guidance in daily practice – all important factors in today’s constrained healthcare environment. In addition to personalizing the Interventional or hybrid operating room with just one click of the user interface, leveraging the Edison platform, the system also harnesses the power of AI with AutoRightv – an advanced AI-based interventional image chain – and Liver ASSIST Virtual Parenchymavi,vii– a 3D visualization software solution designed to provide AI-based virtual parenchymography to help clinicians simulate injections dynamically and perform liver embolization procedures with confidence.
  • AMX Navigate represents GE Healthcare’s latest in portable x-ray technology with a new Zero Click Exam workflow solution and power-assisted Free Motion telescoping column to reduce lift force by an estimated 70 percentviii, helping to decrease X-ray technologist strain . The rugged reliability of the AMX Navigate helps ensure it is ready to perform at the bedside of the patient.
  • Critical Care Suite 2.0 offers a collection of AI algorithms embedded on a mobile x-ray device for case prioritization, automated measurements, and quality control. For the past year, the suite’s AI algorithm to help clinicians assess Endotracheal Tube (ETT) placements has helped clinicians care for an influx of critically ill COVID-19 patients who required ventilation under the FDA COVID-19 imaging guidance. Now, Critical Care Suite 2.0 has received full Food and Drug Administration (FDA) 510(k) clearance.
  • Vscan Air provides clinicians with quick insights at the point of care at a time when they need it most. This wireless and pocket-sized ultrasound device provides exceptionally clear image quality, whole-body scanning capabilities, and intuitive software - all in the palm of the clinician’s hand. A dual-probe enables whole-body scanning – with the flip of the wireless dual probe (for deep and shallow scanning) and a push of a button to capture images. Vscan Air offers a high-performance ultrasound machine in a lightweight, portable device designed to improve patient experience and access to ultrasound technology – involving patients by sharing real-time image sharing as simple as see, snap, send.
  • Enterprise Imaging in the Cloud delivers the power of technology in a smart, digital ecosystem giving radiologists easy and seamless access to GE Healthcare’s latest AI-based tools, data and intelligent technology for visualization, diagnostics and workflow as well as third party algorithms – from anywhere, anytimeix,x. The solution is cloud-based, enabling healthcare systems to manage upgrades instantly and digitally, with little to no new hardware or on-site IT team required.
  • Digital Expert Access is a real-time virtual collaboration solution that is integrated into imaging devices. With imaging experts in short supply and high demand and imaging moving beyond hospital campuses, Digital Expert Access allows sharing of expertise, best practices, and in-the-moment advice, as well as remote console control – all from a distance.
  • ulrichINJECT CT Motion uses automated syringeless technology to support workflow efficiencies. The injector, now approved with RIS/PACS integration, removes the need for manual syringe filling which may minimize examination preparation time and minimize contrast media waste.

A partner of choice creating and investing in new possibilities for the healthcare industry

As innovators, integrators and clinical experts, GE Healthcare is aligning its products and solutions across care pathways, such as oncology, to create end-to-end solutions.

The company is working with industry leaders, such as SOPHiA GENETICS, to deliver on the promise of integrated cancer care by bringing insights across multiple diagnostic modalities with the goal of better targeting and matching treatments to each patient’s cancer type, helping to ensure more effective and personalized treatment. Through the acquisition of Zionexa, the company is advancing precision diagnostics and impacting clinical care by commercializing innovative molecular imaging agents.

Furthermore, GE Healthcare offers deep industry expertise, an ability to merge clinical and data science and a breadth of solutions across pharmaceutical diagnostics, cyclotrons, chemistry synthesis, PET/CT, PET/MR, nuclear medicine, advanced digital solutions, and pharmaceutical partnerships – all to help clinicians enhance patient care from discovery to diagnosis to treatment.

Using input from clinical partners, GE Healthcare has designed technologies and digital solutions to keep up with the ever-changing challenges that exist in the imaging world. The Revolution Apex platform, for example, is designed with advanced technologies intended to:

  • Support one-beat cardiac imaging with motion management;
  • Update their service line from a 40 mm detector and 0.28 second rotation speed up to a 160 mm detector and 0.23 second per rotation speed (FDA 510(k) pending) xi,xii ; and
  • Reduce contrast dose up to 33% potentially.

“I'm a fan of the new Apex [platform] system and all the possibilities around it. For us, it's a big win,” said Johan de Mey, MD, PhD, Chair of Radiology at the Universitair Ziekenhuis, Brussels, Belgium. “In the past, we kept machines as long as possible, and we upgraded them with software. But if the hardware was obsolete, we removed it from the hospital. With the Apex, we have a platform with the latest technology and can easily upgrade as our clinical practice evolves.”

Altogether, GE Healthcare is a partner of choice to thousands of healthcare providers, medical technology innovators, and digital start-ups around the world.

About GE Healthcare

GE Healthcare is the $17 billion* healthcare business of GE. As a leading global medical technology, pharmaceutical diagnostics and digital solutions innovator, GE Healthcare enables clinicians to make faster, more informed decisions through intelligent devices, data analytics, applications and services, supported by its Edison intelligence platform. With over 100 years of healthcare industry experience and around 47,000 employees globally, the company operates at the center of an ecosystem working toward precision health, digitizing healthcare, helping drive productivity and improve outcomes for patients, providers, health systems and researchers around the world. On November 9, 2021, GE announced plans to spin-off GE Healthcare to create a pure-play company at the center of precision health in early 2023.

Spotlight

Spotlight

Related News

Health Technology

Beckman Coulter Unveils DxC 500 AU Chemistry Analyzer, Expanding Portfolio with Proven Six Sigma Performance

Beckman Coulter Diagnostics | January 30, 2024

Beckman Coulter Diagnostics, a clinical diagnostics leader, will unveil its new DxC 500 AU Chemistry Analyzer, an automated clinical chemistry analyzer, at Medlab Middle East in Dubai, taking place February 5-8, 2024. The DxC 500 AU Chemistry Analyzer is one of several recent Beckman Coulter solutions designed to address the complete needs of healthcare systems that are looking to complement central hub laboratories by advancing the technology and capabilities of satellite and independent hospital laboratories. "Healthcare systems around the world are strategically adopting hub-and-spoke models for better efficiency and healthcare access," said Kathleen Orland, Senior Vice President, Business Unit, General Manager, Chemistry and Immunoassay for Beckman Coulter Diagnostics. "Hub-and-spoke clinical laboratory models optimize resources to improve access to testing services and enhance overall standardization for quality testing and positive impact on inventory and cost management across a health system. The new DxC 500 AU Chemistry Analyzer advances capabilities of spoked labs with a broad menu of high-quality assays that deliver consistent, commutable results across Beckman Coulter's AU clinical chemistry systems, positively impacting clinical decision-making and patient outcomes." The DxC 500 AU Chemistry Analyzer features advanced automation technology, onboard guided workflows, and standardized reagents for use across healthcare networks. Its menu of more than 120 assays has been independently and objectively verified for high quality Six Sigma performance, supporting confidence in clinical results, reducing QC trouble shooting and lab operational costs. "Our Six Sigma assessment has shown that the DxC 500 AU analyzer easily exceeds the demands of the new, more stringent CLIA 2024 performance specifications," stated Sten Westgard, Director of Client Services and Technology for Westgard QC. The DxC 500 AU Chemistry Analyzer is for in vitro diagnostic use only. It is available throughout North America and the Middle East. Global commercial availability is planned for March 2024. About Beckman Coulter. Inc. A global leader in advanced diagnostics, Beckman Coulter has challenged convention to elevate the diagnostic laboratory's role in improving patient health for more than 80 years. Our mission is to Relentlessly Reimagine Healthcare, One Diagnosis at a Time – and we do this by applying the power of science, technology and the passion and creativity of our teams. Our diagnostic solutions are used in complex clinical testing, and are found in hospitals, reference laboratories and physician office settings around the globe. We exist to deliver smarter, faster diagnostic solutions that move the needle forward from what's now to what's next. We seek to accelerate care with an extensive clinical menu, scalable lab automation technologies, insightful clinical informatics, and optimize lab performance services. Headquartered in Brea, Calif., with more than 11,000 global team members, Beckman Coulter Diagnostics is proud to be part of Danaher. Danaher is a global science and technology leader. Together we combine our capabilities to accelerate the real-life impact of tomorrow's science and technology to improve human health. ©2024 Beckman Coulter. All rights reserved. Beckman Coulter, the stylized logo, and the Beckman Coulter product and service marks mentioned herein are trademarks or registered trademarks of Beckman Coulter, Inc. in the United States and other countries.

Read More

Health Technology

Rudolf Riester GmbH Announces Global Market Launch of Telemedicine Solution, Showcases ri-sonic® E-Stethoscope + eMurmur® AI Integration

Rudolf Riester GmbH | January 29, 2024

Rudolf Riester GmbH, a global leader in medical technology, proudly announces the full market launch of its comprehensive Telemedicine offering. Already in active use across Europe, the Middle East, and Africa, the solution from the trusted Riester brand delivers industry-leading quality and versatility through integration of a broad range of medical devices to meet the needs of diverse user scenarios. "Since its founding 75 years ago, Riester has been a pioneer in providing accurate and efficient diagnostic devices for front-line healthcare. We have brought this passion and expertise to the creation of our telemedicine solution," said Dr. Georgiana Gasquères, Global Business Unit Director, Telemedicine at Riester. "Now we empower healthcare providers worldwide with the tools they need to deliver accurate diagnosis and exceptional care to every patient, everywhere, and to do it more sustainably." Riester is demonstrating its Telemedicine Case and Cart offerings at the Arab Health show in Dubai, 29 January – 1 February 2024, at booth SA.E30. Traveling nurses with South African healthcare innovator EQiGate are already evaluating dozens of patients every week with the Riester Telemedicine Case. "EQiGate selected the Riester Telemedicine solution for its high quality, comprehensiveness, and versatile, Windows-based compatibility with our portfolio of operating applications," stated Braam Kruger, CEO at EQiGate. "The Riester solution integrates seamlessly with our Hospital at Home concept, enabling us to bring the hospital to the patient, a healthcare paradigm shift that yields significant cost and time savings for both the healthcare system and the patient." At Arab Health, Riester is showcasing the integration of their industry-leading ri-sonic® E-stethoscope with the eMurmur® AI platform. Digital auscultation with ri-sonic and eMurmur AI enables the early detection and analysis of heart murmurs, informing better, more timely decisions about treatment pathways. To demonstrate their commitment to raising heart health awareness and improving quality of life through accurate and efficient diagnosis, Riester is offering complimentary advisory heart checks to all exhibition attendees at their booth at Arab Health, conducted by a professional cardiologist. "Our participation at Arab Health reaches beyond showcasing our technological advancements; it is about educating and engaging with the public – including Arab Health attendees – and healthcare professionals," said Irina Zhdanova, CEO of Riester. "By providing free advisory heart checks, we emphasise the significance of regular cardiac health assessments and demonstrate how innovative technology can be a pivotal tool in advancing diagnostic cardiac care to improve health outcomes. This is a perfect way to honor Riester’s 75-year heritage and act on our vision and mission." About Rudolf Riester GmbH Since its founding in Germany in 1948, Rudolf Riester GmbH has been a pioneering force in improving quality of life through accurate and efficient diagnosis on the front-line of healthcare. By developing and manufacturing high-quality, market-leading medical diagnostic products, Riester has earned a global reputation for quality, reliability, and innovation in the healthcare sector, with a presence in over 150 countries. Specializing in diagnostic devices, Riester's product portfolio includes telemedicine solutions as well as stethoscopes, blood pressure monitors, otoscopes, ophthalmoscopes, and other medical equipment. Riester is part of the Halma plc group of companies.

Read More

Digital Healthcare

UCI Health Reaches Definitive Agreement to Acquire Four Southern California Hospitals From Tenet Healthcare Corporation

UCI Health | February 02, 2024

The Regents of the University of California, on behalf of the University of California, Irvine, has entered into a definitive agreement with Tenet Healthcare Corporation to acquire Tenet's Pacific Coast Network. The network will become part of UCI Health, the clinical enterprise of UC Irvine. "UC Irvine has deepened its healthcare commitment to the future of Orange County, our region and California," said UC Irvine Chancellor Howard Gillman. "This journey in healthcare is deeply intertwined with the University of California's dedication to bettering our communities, expanding access to premier healthcare, and pioneering the medical innovations of tomorrow, today. Our vision will bridge gaps in regional care and reinforce UCI's place among the nation's leading academic health systems while advancing solutions to challenges facing healthcare." Pending customary regulatory approvals, clearances, and closing conditions, the proposed acquisition would bring four medical centers in Lakewood, Los Alamitos, Fountain Valley and Placentia and associated outpatient locations into the UCI Health system. UCI Health currently delivers care at UCI Medical Center in Orange and a growing network of multispecialty care centers. "At UCI Health, we are excited to add these new care sites to the UCI Health network and extend the benefits of our compassionate, high-level care, clinical innovation, and scientific discovery," said Chad Lefteris, president and chief executive officer of UCI Health. "As Orange County's only academic health system, UCI Health is unique in its ability to offer the highest level of advanced care powered by the research and innovation of a world-class public research institution." UCI Health recognizes a unique opportunity to build on the quality care already being delivered in the communities served by Tenet Healthcare's Pacific Coast Network. "These four hospitals are well-regarded in their communities for providing high-quality, compassionate care," said Saum Sutaria, M.D., chairman and chief executive officer of Tenet Healthcare. "The local communities will benefit from the nationally recognized advancements, medical knowledge, research, and community focus that UCI Health brings as an innovative academic health system. UCI Health recognizes a unique opportunity to build on the quality care already being delivered in the communities served by the Pacific Coast Network." In a region with a population greater than that of two dozen states, UCI Health operates the only Level I trauma center, locally based National Cancer Institute-designated comprehensive cancer center, high-risk perinatal-neonatal service and is the largest regional burn center and leading provider of complex tertiary and quaternary care. The system's clinical excellence has consistently placed UCI Health in the top 10 for quality and safety among the nation's leading comprehensive academic health systems. The acquisition also means more patients will have access to advanced therapies in the region's largest and most diverse portfolio of clinical trials, ranging from cancer to neurosciences, digestive diseases, orthopedics and internal medicine specialties. UCI Health and Tenet Healthcare's Pacific Coast Network patients can continue receiving care at their local facilities as they normally would from the care teams they know and trust. The transaction is expected to be completed in spring 2024, subject to customary regulatory approvals, clearances, and closing conditions. "It is a privilege to provide world-class care to Californians and we are excited to welcome the clinicians and co-workers from these Tenet Healthcare sites to UCI Health as partners in improving the health of local communities," Lefteris said. About UCI Health UCI Health is the clinical enterprise of the University of California, Irvine, and the only academic health system in Orange County. Patients can access UCI Health at primary and specialty care offices across Orange County and at its main campus, UCI Medical Center in Orange, Calif. The 459-bed, acute care hospital, listed among America's Best Hospitals by U.S. News & World Report for 23 consecutive years, provides tertiary and quaternary care, ambulatory and specialty medical clinics, behavioral health and rehabilitation services. UCI Medical Center is home to Orange County's only National Cancer Institute-designated comprehensive cancer center, high-risk perinatal/neonatal program and American College of Surgeons-verified Level I adult and Level II pediatric trauma center, gold level 1 geriatric emergency department and regional burn center. About UC Irvine About the University of California, Irvine: Founded in 1965, UCI is a member of the prestigious Association of American Universities and is ranked among the nation's top 10 public universities by U.S. News & World Report. The campus has produced five Nobel laureates and is known for its academic achievement, premier research, innovation and anteater mascot. Led by Chancellor Howard Gillman, UCI has more than 37,000 students and offers 224 degree programs. It's located in one of the world's safest and most economically vibrant communities and is Orange County's second-largest employer, contributing $7 billion annually to the local economy and $8 billion statewide. About Tenet Healthcare Tenet Healthcare Corporation is a diversified healthcare services company headquartered in Dallas. Our care delivery network includes United Surgical Partners International, the largest ambulatory platform in the country, which operates or has ownership interests in more than 480 ambulatory surgery centers and surgical hospitals. We also operate 58 acute care and specialty hospitals, approximately 110 other outpatient facilities, a network of leading employed physicians and a global business center in Manila, Philippines. Our Conifer Health Solutions subsidiary provides revenue cycle management and value-based care services to hospitals, health systems, physician practices, employers, and other clients. Across the Tenet enterprise, we are united by our mission to deliver quality, compassionate care in the communities we serve.

Read More